Trials / Completed
CompletedNCT01282606
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
An Open Label, Non-randomized Dose-escalation Study to Assess Safety and Tolerability of SI-6603 in Patients With Lumbar Disc Herniation (Phase II Study)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Seikagaku Corporation · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of SI-6603 in lumbar disc herniation patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SI-6603 | SI-6603 is administrated into the nucleus pulposus of an intervertebral disc. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2012-08-01
- First posted
- 2011-01-25
- Last updated
- 2023-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01282606. Inclusion in this directory is not an endorsement.